HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Supplemental Data All Versions of this Article: jnumed.109.061879v1 50/8/1332    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Related articles in JNM Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Liu, J. Articles by Öz, O. K. Search for Related Content PubMed PubMed Citation Articles by Liu, J. Articles by Öz, O. K.

Retention of the Radiotracers ⁶⁴Cu-ATSM and ⁶⁴Cu-PTSM in Human and Murine Tumors Is Influenced by MDR1 Protein Expression

¹ Department of Radiology, UT Southwestern Medical Center at Dallas, Dallas, Texas; ² Department of Surgery, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, China; and ³ Prince Henry's Institute of Medical Research, Clayton Vic, Australia

Correspondence: For correspondence or reprints contact: Orhan K. Öz, Department of Radiology, UT Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd., Dallas, TX 75390-9153. E-mail: Orhan.Oz{at}UTSouthwestern.edu

Tumor hypoxia is often associated with resistance to chemotherapy. Multidrug resistance type 1 (MDR1) protein is a member of the adenosine triphosphate binding cassette (ABC) proteins, some of which are involved in the multidrug resistance (MDR) phenotype in tumors. Many studies have focused on the role of these proteins in modulating drug resistance, but their effect on retention of imaging agents is less well studied. To study the role of MDR1 expression on the accumulation of ⁶⁴Cu-diacetyl-bis(N4-methylthiosemicarbazone) (⁶⁴Cu-ATSM) and ⁶⁴Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) (⁶⁴Cu-PTSM) in human tumors in vitro and in vivo, we used a model system composed of a low MDR1–expressing parent uterine sarcoma cell line and a daughter cell line selected for overexpression of MDR1. Aromatase knockout (ArKO) mice that spontaneously developed liver tumors were used as an additional in vivo model to study the effect of MDR expression on ⁶⁴Cu-ATSM and -PTSM retention. Methods: Biodistribution experiments after injection of ⁶⁴Cu-ATSM or -PTSM were performed in wild-type mice, ArKO mice, and ArKO mice bearing liver tumors (n = 3–5/group), and in nude mice bearing human tumor xenografts for in vivo PET/CT. Liver expression of Abcb1a and Abcb1b, the MDR1 proteins in mouse liver, was determined by real-time polymerase chain reaction. ⁶⁴Cu-ATSM and -PTSM accumulation and efflux studies were conducted in tumor cell lines. The uptake experiments were repeated after knockdown of MDR1 protein expression using MDR1-specific small interfering RNAs. Results: In vivo, the hepatic tumors had a lower percentage injected dose per gram of ⁶⁴Cu-ATSM or -PTSM and more highly expressed Abcb1b than did wild-type liver or nontumor-bearing ArKO liver. High MDR1–expressing tumors showed lower tracer activity on PET/CT images. In vitro, cells highly expressing MDR1 had significantly decreased ⁶⁴Cu-ATSM and -PTSM retention and enhanced efflux. Knockdown of MDR1 expression significantly enhanced the ⁶⁴Cu-ATSM and -PTSM retention and decreased the efflux in MDR1-positive cells. Conclusion: The expression of MDR1 glycoprotein (or its equivalents in mice) affects the retention of ⁶⁴Cu-ATSM and -PTSM in the human and murine tumors tested. These results may have implications for clinical hypoxia imaging in tumors and the therapeutic efficacy of ⁶⁴Cu-ATSM.

Key Words: MDR1 • P-glycoprotein (Pgp) • hypoxia imaging • copper-diacetyl-bis(N4-methylthiosemicarbazone) • copper-pyruvaldehyde-bis(N4-methylthiosemicarbazone)

COPYRIGHT © 2009 by the Society of Nuclear Medicine, Inc.

Related articles in JNM:

This Month in JNM

JNM 2009 50: 11A-12A. [Full Text]